As of 8/27/2024, you are enrolled in the Zepbound® (tirzepatide) Savings Card Program without coverage for Zepbound. Lilly has extended the non-covered benefit program through 12/31/2025. If you continue to meet the eligibility requirements, you can continue to pay $650 per 1-month prescription. Governmental beneficiaries excluded, terms and conditions apply.See the full terms and conditions here: https://e.lilly/4int5BB See Indications and Safety Summary including Warnings: https://e.lilly/bRTJK_risk Reply STOP to opt out. Msg & Data Rates May Apply